terazosin has been researched along with Insulin Resistance in 1 studies
Terazosin: induces decreased blood pressure; used in the treatment of benign prostatic hyperplasia
Insulin Resistance: Diminished effectiveness of INSULIN in lowering blood sugar levels: requiring the use of 200 units or more of insulin per day to prevent HYPERGLYCEMIA or KETOSIS.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Valle, R | 1 |
Semplicini, A | 1 |
Serena, L | 1 |
Gebbin, A | 1 |
Fontebasso, A | 1 |
Gerardi, G | 1 |
De Toni, R | 1 |
Pessina, AC | 1 |
1 trial available for terazosin and Insulin Resistance
Article | Year |
---|---|
[Pressure and metabolic effects of terazosin in essential hypertension].
Topics: Adrenergic alpha-Antagonists; Adult; Atrial Natriuretic Factor; Blood Glucose; Double-Blind Method; | 1994 |